FAST Biomedical Adds Dillon to Board

Jim Dillon

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Indianapolis-based FAST BioMedical has added Jim Dillon to its board of directors. Dillon serves as chief executive officer of  Massachusetts-based Reprieve Cardiovascular. Dillon is also a former St. Jude Medical and Abiomed executive. 

He has more than 30 years of experience in healthcare. While at St. Jude, Dillon oversaw the Medical’s America’s product portfolio including Structural Heart and Heart Failure.  At Abiomed, Dillon led US core business growth with a strategic focus on native heart recovery.